Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

CME

Invitation/Ticketed Event

Invited Lectureship

Award Recipient

Self-Assessment

Social

Industry

20 Views

Evaluation View Video

IBD

Perioperative

Geriatric Track

APP Track

DEI Track

Live Stream

LiveQ&A

Session: Perioperative Optimization of the IBD Patient: How Many Biologics is Too Many?

Perioperative Optimization of the IBD Patient: How Many Biologics is too Many?

Sunday, May 11, 2025

12:30 PM - 1:20 PM PT

Location: Ballroom 6C-F, Upper Level

Co-Moderator(s)

Kinga S. Olortegui, MD, MS, FACS

Assistant Professor
UChicago Medicine
Chicago, IL, United States

Disclosure information not submitted.

All of the relevant financial relationships listed below have been mitigated.

Jaime Bohl, MD: This individual has no financial relationships with ineligible companies.

Kinga S. Olortegui, MD, MS, FACS: This individual has no financial relationships with ineligible companies.

Learning Objectives:

Upon completion of this activity, participants should be able to:

Optimize new IBD medications in the perioperative setting.
Identify challenges in unique IBD patient populations.
Utilize technology for improved diagnosis in the treatment of IBD.

CME Credit: 0.75
Self-Assessment Credit: 0.75
Contact Hours: 0.75

Inflammatory Bowel Disease is a complex chronic disease requiring a multidisciplinary approach to care. Despite advances in medical management, many patients will eventually need operative intervention. This symposium will discuss different aspects of medical management and perioperative optimization of the IBD patient.